Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 981 | 930 | 1043 | 592 | 647 | - |
Fund Return | -1.94% | -6.97% | 4.27% | -16.02% | -8.33% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
China Universal Consumer Industries | 11.54B | -3.29 | -12.35 | 11.87 | ||
China Universal Selective Mixed Sec | 8.97B | -1.48 | -11.00 | 7.80 | ||
China Universal Blue Chip Equity Fu | 4.28B | -0.85 | -9.71 | 9.47 | ||
China Universal Healthcare Serv mix | 3.92B | -1.74 | -12.02 | - | ||
China Universal Waiyan Gr Theme Eq | 3.47B | -1.01 | -0.91 | 4.80 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICBCCS QY Medical Eq | 10.6B | -1.41 | -10.20 | - | ||
CMF CNI Bio Health Index | 9.81B | -3.97 | -20.15 | - | ||
Hwabao WP CSI Medical Index | 6.3B | -4.66 | -16.63 | - | ||
GF YiLiao BaoJian Eq A | 6.01B | -1.85 | -14.70 | - | ||
China Universal Healthcare Serv mix | 3.92B | -1.74 | -12.02 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shanghai Allist Pharmaceuticals Co | CNE100005XJ7 | 5.18 | 71.60 | -0.28% | |
Shanghai Junshi Biosciences Co | CNE1000041Z1 | 5.15 | 27.27 | -0.04% | |
Shenzhen Mindray Bio-Medical | CNE100003G67 | 4.88 | 251.19 | +4.66% | |
Pharmaron Beijing | CNE100003JW4 | 4.78 | 26.26 | +1.04% | |
Beigene | CNE100005XT6 | 4.70 | 195.00 | -1.96% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Neutral | Sell |
Technical Indicators | BUY | Sell | Strong Sell |
Summary | Buy | Neutral | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review